ESO Session: Is Innovation Affordable?
Not eligible for ESCO credits
26.09.2015
Vienna, Austria
COURSES AND SEMINARS
Description
Chair: F.A. Peccatori, IT
Co-Chair: F. De Lorenzo, BE
The European School of Oncology is pleased to announce the session "Is Innovation Affordable?", which will be held during the European Cancer Congress 2015 (ECC2015) on Saturday 26 Septeber 2015 (16:45-18:15, Hall A5) in Vienna, chaired by Dr. A. Costa and Mr. F. De Lorenzo.
Attendance to the session is granted to all ECC2015 registered participants.
If you are participating in ECC2015, please visit our booth number 504. The ESO educational programme 2016 and information about our activities, including ABC3, will be available there.
Co-Chair: F. De Lorenzo, BE
The European School of Oncology is pleased to announce the session "Is Innovation Affordable?", which will be held during the European Cancer Congress 2015 (ECC2015) on Saturday 26 Septeber 2015 (16:45-18:15, Hall A5) in Vienna, chaired by Dr. A. Costa and Mr. F. De Lorenzo.
Attendance to the session is granted to all ECC2015 registered participants.
If you are participating in ECC2015, please visit our booth number 504. The ESO educational programme 2016 and information about our activities, including ABC3, will be available there.
| Session held within |
 |
Faculty list
FACULTY
M. Aapro, Clinique de Genolier, CH
R. Bergström, European Federation of Pharmaceutical Industries and Associations, Brussels, BE
P. Cornes, Clinical Outcomes Group, Bristol, UK
F. De Lorenzo, European Cancer Patient Coalition, Brussels, BE
F.A. Peccatori, European School of Oncology, Milan, IT
M. Piccart, Jules Bordet Institute, Brussels, BE
E. Sharpe, The Institute of Cancer Research, London, UK
Programme
SESSION PROGRAMME
| Saturday, 26 September 2015 16:45-18:15 (Hall A5) | ||
| 16:45 | Economics for oncologists: The reality of costs P. Cornes, UK | |
| 17:00 | Concerns or solutions: The ESO Innovation Task Force M. Aapro, CH | |
| 17:10 | The World Oncology Forum: Treat the treatable F.A. Peccatori, IT | |
| 17:20 | The ESMO initiative on affordable drugs M. Piccart, BE | |
| 17:35 | Affordability of innovative cancer medicine: A research perspective E. Sharpe, UK | |
| 17:50 | Industry perspective on valuation of innovation R. Bergström, BE | |
| 18:00 | Roundtable discussion with the audience | |
| 18:15 | End of the session | |